This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Innovations of Inventor Wen Wei
Introduction
Wen Wei is an accomplished inventor based in Cockeysville, MD (US). He holds 2 patents that contribute significantly to the field of biomedical research. His work focuses on advanced glycation end products and their implications in vascular diseases.
Latest Patents
Wen Wei's latest patents include a human soluble receptor for advanced glycation end products (sRAGE) and methods of preparing human sRAGE, as well as treatment methods using sRAGE. The first patent provides a method for recombinant production of human sRAGE in mammalian cells, which includes a human sRAGE that has undergone mammalian post-translational modification. This innovation also outlines a method for treating vascular diseases, injuries, or inflammation in mammals by administering a composition comprising human sRAGE. The second patent describes nucleic acid modules for the expression and tagging of membrane proteins. These modules include a receptor for advanced glycation end products (RAGE) signal sequence, a nucleic acid sequence encoding a tag, and a multiple cloning sequence (MCS). This technology allows for the cloning and expression of any membrane protein of interest, particularly Type I and Type III membrane proteins.
Career Highlights
Wen Wei works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His contributions to the field have been recognized through his innovative patents and research.
Collaborations
Wen Wei collaborates with notable colleagues, including Li Lin and Edward G Lakatta. Their combined expertise enhances the research and development of new biomedical technologies.
Conclusion
Wen Wei's innovative work in the field of biomedical research, particularly regarding advanced glycation end products, showcases his significant contributions to science and medicine. His patents reflect a commitment to improving treatment methods for vascular diseases and advancing the understanding of membrane proteins.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile